Citation: | QIN Wei, HUANG Xiao-hong, HUANG Hui-lian. Expression and clinical significance of HIF-1α, VEGF and AMH in patients with polycystic ovary syndrome[J]. Chinese Journal of General Practice, 2021, 19(10): 1693-1696. doi: 10.16766/j.cnki.issn.1674-4152.002144 |
[1] |
MANN A, SAGILI H, SUBBAIAH M. Pregnancy outcome in women with polycystic ovary syndrome[J]. J Obstet Gynaecol India, 2020, 70(5): 360-365. doi: 10.1007/s13224-020-01356-y
|
[2] |
刘洪娟, 易蕾, 岳进, 等. 朱琏针法治疗肥胖型多囊卵巢综合征的疗效及对患者生活质量的影响[J]. 中华全科医学, 2019, 17(4): 601-604.
|
[3] |
WANG J, WU X H. The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome[J]. Endokrynol Pol, 2020, 71(2): 134-145. doi: 10.5603/EP.a2020.0002
|
[4] |
BAO L, SYED R, ALOAHD M S. Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients[J]. Mol Biol Rep, 2019, 46(6): 5821-5829. doi: 10.1007/s11033-019-05015-y
|
[5] |
GOMES M K O, ANTONINO D C, BALARIN M A S, et al. Haplotype analysis of VEGF gene polymorphisms in polycystic ovary syndrome[J]. Gynecol Endocrinol, 2019, 35(10): 847-850. doi: 10.1080/09513590.2019.1604659
|
[6] |
KUYUCU Y, SENCAR L, TAP Ö, et al. Investigation of the effects of vitamin D treatment on the ovarian AMH receptors in a polycystic ovary syndrome experimental model: An ultrastructural and immunohistochemical study[J]. Reprod Biol, 2020, 20(1): 25-32. doi: 10.1016/j.repbio.2020.01.001
|
[7] |
CALZADA M, LOPEZ N, NOGUERA J A, et al. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome[J]. J Obstet Gynaecol, 2019, 39(8): 1130-1136. doi: 10.1080/01443615.2019.1587604
|
[8] |
BELOSI C, SELVAGGI L, APA R, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?[J]. Hum Reprod, 2006, 21(12): 3108-3115. doi: 10.1093/humrep/del306
|
[9] |
中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6. doi: 10.3760/cma.j.issn.0529-567x.2018.01.002
|
[10] |
胡斌. 抗苗勒管激素和内分泌代谢指标在多囊卵巢综合征诊断中的应用[J]. 当代医学, 2020, 26(26): 153-154. doi: 10.3969/j.issn.1009-4393.2020.26.066
|
[11] |
叶娅琼, 蒋瑶枝, 陈君霞, 等. 子宫内膜预处理对多囊卵巢综合征不孕患者的促排卵疗效[J]. 中华全科医学, 2020, 18(9): 1530-1533. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202009029.htm
|
[12] |
乔杰, 齐新宇, 徐雅兰, 等. 关注影响女性健康的重要生殖内分泌疾病多囊卵巢综合征[J]. 中国实用妇科与产科杂志, 2020, 36(1): 1-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202001001.htm
|
[13] |
王笑颜, 王海燕, 沈翠芬, 等. 多囊卵巢综合征人群血清胰岛素抵抗与内分泌激素的临床分析[J]. 中国卫生检验杂志, 2020, 30(7): 843-845. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ202007022.htm
|
[14] |
BAHRAMREZAIE M, AMIDI F, ALEYASIN A, et al. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: A triple-blind randomized clinical trial[J]. J Assist Reprod Genet, 2019, 36(8): 1701-1712. doi: 10.1007/s10815-019-01461-6
|
[15] |
金纬纬, 蔡平生, 方轶萍, 等. 多囊卵巢综合征患者子宫内膜HIF-1α表达及与子宫内膜容受性的关系[J]. 浙江中西医结合杂志, 2016, 26(7): 612-614, 626. doi: 10.3969/j.issn.1005-4561.2016.07.006
|
[16] |
张莉. 血清ES、VEGF水平和多囊卵巢综合征患者血清胰岛素及卵巢间质血流的相关性分析[J]. 中国性科学, 2020, 29(2): 78-81. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ202002025.htm
|
[17] |
蒋雪霞, 尹道英, 李晓玲, 等. 血清VEGF、ES水平与多囊卵巢综合征患者卵巢间质血流的关系[J]. 中国医药导报, 2019, 16(15): 85-87, 99. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201915022.htm
|
[18] |
KUREK E M, SAHIN E G, YAYLA A C, et al. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome[J]. J Obstet Gynaecol, 2019, 39(7): 975-980. doi: 10.1080/01443615.2019.1581754
|
[19] |
丁娇, 邵军晖, 简皓, 等. 抗苗勒氏管激素(AMH)与多囊卵巢综合征相关性的临床研究[J]. 当代医学, 2018, 24(28): 93-95. doi: 10.3969/j.issn.1009-4393.2018.28.037
|